Population Health Sciences

You are here

Publications

Found 220 results
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Nosyk B, Zang X, Krebs E, Enns B, Min JE, Behrends CN, Del Rio C, Dombrowski JC, Feaster DJ, Golden M et al..  2020.  Ending the HIV epidemic in the USA: an economic modelling study in six cities.. Lancet HIV.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Chagoya G, Kwatra SG, Nanni CW, Roberts CM, Phillips SM, Nullmeyergh S, Gilmore SP, Spasojevic I, Corcoran DL, Young CC et al..  2020.  Efficacy of osimertinib against EGFRvIII+ glioblastoma.. Oncotarget. 11(22):2074-2082.
Brenner SK, Kaushal R, Grinspan Z, Joyce C, Kim I, Allard RJ, Delgado D, Abramson EL.  2016.  Effects of health information technology on patient outcomes: a systematic review.. J Am Med Inform Assoc. 23(5):1016-36.
Brenner SK, Kaushal R, Grinspan Z, Joyce C, Kim I, Allard RJ, Delgado D, Abramson EL.  2016.  Effects of health information technology on patient outcomes: a systematic review.. J Am Med Inform Assoc. 23(5):1016-36.
Ponirakis G, Abdul-Ghani MA, Jayyousi A, Almuhannadi H, Petropoulos IN, Khan A, Gad H, Migahid O, Megahed A, DeFronzo R et al..  2020.  Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.. BMJ Open Diabetes Res Care. 8(1)
Pesko MF, Kenkel DS, Wang H, Hughes JM.  2016.  The effect of potential electronic nicotine delivery system regulations on nicotine product selection.. Addiction. 111(4):734-44.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Berg AT, Coryell J, Saneto RP, Grinspan ZM, Alexander JJ, Kekis M, Sullivan JE, Wirrell EC, Shellhaas RA, Mytinger JR et al..  2017.  Early-Life Epilepsies and the Emerging Role of Genetic Testing.. JAMA Pediatr. 171(9):863-871.
Ancker JS, Mauer E, Kalish RB, Vest JR, J Gossey T.  2019.  Early Adopters of Patient-Generated Health Data Upload in an Electronic Patient Portal.. Appl Clin Inform. 10(2):254-260.
D
Kapadia SN, Gulick RM.  2019.  Drug Costs: What Can Infectious Diseases Physicians Do? J Infect Dis.
Dubin MJ, Ilieva IP, De Deng Z-, Thomas J, Cochran A, Kravets K, Brody BD, Christos PJ, Kocsis JH, Liston C et al..  2019.  A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).. J Affect Disord. 249:286-293.
Dubin MJ, Ilieva IP, De Deng Z-, Thomas J, Cochran A, Kravets K, Brody BD, Christos PJ, Kocsis JH, Liston C et al..  2019.  A double-blind pilot dosing study of low field magnetic stimulation (LFMS) for treatment-resistant depression (TRD).. J Affect Disord. 249:286-293.
Krebs E, Enns B, Wang L, Zang X, Panagiotoglou D, Del Rio C, Dombrowski J, Feaster DJ, Golden M, Granich R et al..  2019.  Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis.. PLoS One. 14(5):e0217559.
Al'Aref SJ, Singh G, van Rosendael AR, Kolli KK, Ma X, Maliakal G, Pandey M, Lee BC, Wang J, Xu Z et al..  2019.  Determinants of In-Hospital Mortality After Percutaneous Coronary Intervention: A Machine Learning Approach.. J Am Heart Assoc. 8(5):e011160.
Brandt PS, Pacheco JA, Adekkanattu P, Sholle ET, Abedian S, Stone DJ, Knaack DM, Xu J, Xu Z, Peng Y et al..  2022.  Design and validation of a FHIR-based EHR-driven phenotyping toolbox.. J Am Med Inform Assoc. 29(9):1449-1460.
Kaur S, Silver G, Samuels S, Rosen AH, Weiss M, Mauer EA, Gerber LM, Greenwald BM, Traube C.  2020.  Delirium and Developmental Disability: Improving Specificity of a Pediatric Delirium Screen.. Pediatr Crit Care Med. 21(5):409-414.
Wang F, Casalino LPeter, Khullar D.  2019.  Deep Learning in Medicine-Promise, Progress, and Challenges.. JAMA Intern Med. 179(3):293-294.
Zeng X, Wang F, Luo Y, Kang S-G, Tang J, Lightstone FC, Fang EF, Cornell W, Nussinov R, Cheng F.  2022.  Deep generative molecular design reshapes drug discovery.. Cell Rep Med. 3(12):100794.
Ono JG, Kim BI, Zhao Y, Christos PJ, Tesfaigzi Y, Worgall TS, Worgall S.  2020.  Decreased sphingolipid synthesis in children with 17q21 asthma-risk genotypes.. J Clin Invest. 130(2):921-926.
Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Zhang Y, Nordvig AS et al..  2023.  Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.. Nat Med. 29(1):226-235.
Zhang H, Zang C, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Zhang Y, Nordvig AS et al..  2023.  Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes.. Nat Med. 29(1):226-235.